Shingles Risk for Cardiovascular and Metabolic Disease Patients

Research indicates a bidirectional relationship between shingles and cardiovascular health, suggesting that individuals with cardiovascular metabolic diseases are at a higher risk of developing the infection, while those who contract shingles face an increased risk of future heart-related events.

According to reporting by am730, patients with cardiovascular metabolic diseases are considered a high-risk group for shingles. This connection highlights the complex interplay between chronic systemic health conditions and the reactivation of the varicella-zoster virus.

Shingles, also known as herpes zoster, occurs when the varicella-zoster virus—the same virus responsible for chickenpox—reactivates in the body after remaining dormant in nerve tissue. This reactivation typically manifests as a painful, itchy, or tingly rash that appears on one side of the face or body.

The impact of shingles on the cardiovascular system is significant. Data analyzed by researchers and published in the Journal of the American Heart Association found that adults who experienced shingles had a nearly 30% increased associated risk of suffering a future cardiovascular event, such as a stroke or heart attack.

This finding suggests that the inflammatory response triggered by the virus may contribute to vascular instability or accelerate the progression of existing cardiovascular issues.

Conversely, existing cardiovascular disease may make an individual more susceptible to the virus. Research presented at the Canadian Cardiovascular Congress, led by researchers from McMaster University, revealed that having heart disease increased an individual’s chances of developing shingles by 15%.

The risk increases further for those managing multiple health challenges. The McMaster University study found that the risk of shingles rose up to 27% among adults with two or more chronic conditions, which may include cardiovascular disease, diabetes, asthma, or chronic obstructive pulmonary disease (COPD).

This increased vulnerability is most pronounced in adults aged 65 and older. Researchers attribute this trend to immunosenescence, which is the natural weakening of the immune system that occurs with age, reducing the body’s ability to suppress the dormant varicella-zoster virus.

Beyond the cardiovascular risks, shingles can lead to several other serious medical complications. The most frequent is postherpetic neuralgia (PHN), a condition characterized by debilitating nerve pain that persists for three months or longer after the rash has cleared.

In some cases, the infection can affect the face, leading to Ramsay-Hunt syndrome. Other potential complications include hearing loss, neurological issues, and vision problems depending on which nerves the virus affects during reactivation.

Preventive measures are central to managing these risks. Medical guidelines emphasize the importance of vaccination to prevent the initial outbreak of shingles and the subsequent risk of cardiovascular complications.

Vaccines are currently recommended for adults aged 50 and older, as well as for adults aged 19 and older who have compromised immune functions. Because most adults born before 1995 have had chickenpox, they carry the latent virus and are eligible for protection.

The link between viral infections and heart health underscores the necessity of integrated care. Recognizing that a shingles outbreak may be a marker for cardiovascular vulnerability allows healthcare providers to better monitor high-risk populations.

By combining vaccination with the management of chronic metabolic conditions, the risk of both the infection and its associated cardiovascular events can be mitigated.